🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Dow, DuPont merger wins U.S. antitrust approval with conditions

Published 16/06/2017, 00:18
© Reuters. FILE PHOTO: The Dow logo is seen on a building in downtown Midland, Michigan
DJI
-
DOW
-
BAYGN
-
SYENF
-
DD
-
MON
-

By Diane Bartz

(Reuters) - DuPont (N:DD) and Dow Chemical Co (N:DOW) have won U.S. antitrust approval to merge on condition that the companies sell certain crop protection products and other assets, according to a court filing on Thursday.

The asset sales required by U.S. antitrust enforcers were similar to what the companies had agreed to give up in a deal they struck with European regulators in March. The deal is one of several big mergers by farm suppliers, and the antitrust approval was quickly denounced by the head of the National Farmers Union, saying that farmers would face higher costs.

The Justice Department said the asset sales would prevent price hikes or lost innovation.

Dow and DuPont announced the deal in December 2015 in what was billed as an all-stock merger valued at $130 billion (101.93 billion pounds).

According to the filing in U.S. District Court for the District of Columbia, the assets to be sold include DuPont's Finesse herbicide for winter wheat and Rynaxypyr insecticides, which the Justice Department said had U.S. annual sales of more than $100 million.

In addition, Dow will sell its U.S. acid copolymers and ionomers business. The products are used to make food packaging and other goods.

The president of the National Farmers Union, Roger Johnson called the antitrust approval "deeply disappointing."

"Clearly, the Trump administration is content allowing our country’s consolidation complex to continue," Johnson said in a statement. "The combination of Dow and DuPont, coupled with other pending mergers, ... drives up costs for farmers’ inputs, and it reduces the incentive for the remaining agricultural input giants to compete."

The Justice Department and Federal Trade Commission, which share the work of antitrust enforcement, have reviewed or are reviewing no fewer than four deals involving corporate titans that supply U.S. farmers.

In addition to Dow and DuPont merger deal, Bayer (DE:BAYGn) has a deal to buy Monsanto (N:MON), and ChemChina is purchasing Syngenta (S:SYNN). In addition, fertiliser companies Potash Corp and Agrium are planning a merger.

After Dow completes the merger with DuPont, the companies have said that they would split into three separate companies specializing in material sciences, speciality products, and seeds and agrochemicals.

"As originally proposed, the merger would have eliminated important competition between Dow and DuPont in the development and sale of insecticides and herbicides that are vital to American farmers who plant winter wheat and various speciality crops," acting Assistant Attorney General Andrew Finch said in a statement, adding that the merged company would have also gained a monopoly over ethylene derivatives used to manufacture food packaging and other products.

Finch said the settlement "will preserve vigorous competition."

Analyst Brett Wong of Piper Jaffrey Co said he did not foresee another round of consolidation in the agricultural supply business in the near future. "It's going to take some time for the current dust to settle," he said.

© Reuters. FILE PHOTO: The Dow logo is seen on a building in downtown Midland, Michigan

Dow and DuPont have already received clearance to merge from Europe, China and Brazil. They are now awaiting approval from just a handful of countries, including Canada and Mexico.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.